{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041978","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2026-09-09T21:00:13+00:00","discovered_at":"2026-09-09T21:02:02.171734+00:00","generated_at":"2026-09-09T21:02:11.165595+00:00","sec_items":["1.01","2.03","3.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Glucotrack settles Alto debt dispute with $2M cash and $2M convertible note","bullets":["Settlement with Alto resolves ~$10.9M asserted debt from Apimeds Pharmaceuticals; Glucotrack and others jointly liable.","Pays $2.0M initial cash, issues $2.0M convertible note (5% interest, quarterly $500k payments from Nov 30, 2026 to Aug 31, 2027), plus up to $125k legal fees.","Note convertible into GCTK common at $2.98/share, subject to 9.99% beneficial ownership cap and Nasdaq limits.","Alto's release effective upon full payment; default triggers acceleration and increased interest."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041978","json":"https://secwatch.observer/filing/0001493152-26-041978.json","markdown":"https://secwatch.observer/filing/0001493152-26-041978.md","text":"https://secwatch.observer/filing/0001493152-26-041978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/0001493152-26-041978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T21:02:11.165595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}